Cargando…
Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs
Cancer chemotherapy sensitizers hold the key to maximizing the potential of standard anticancer treatments. We have a long-standing interest in developing and validating inhibitors of the DNA repair enzyme tyrosyl-DNA phosphodiesterase 1 (TDP1) as chemosensitizers for topoisomerase I poisons such as...
Autores principales: | Leung, Euphemia, Patel, Jinal, Hollywood, Jennifer A., Zafar, Ayesha, Tomek, Petr, Barker, David, Pilkington, Lisa I., van Rensburg, Michelle, Langley, Ries J., Helsby, Nuala A., Squire, Christopher J., Baguley, Bruce C., Denny, William A., Reynisson, Jóhannes, Leung, Ivanhoe K. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593127/ https://www.ncbi.nlm.nih.gov/pubmed/34159519 http://dx.doi.org/10.1007/s40487-021-00158-0 |
Ejemplares similares
-
GPCR Modulation of Thieno[2,3-b]pyridine Anti-Proliferative Agents
por: Zafar, Ayesha, et al.
Publicado: (2017) -
Investigation into Improving the Aqueous Solubility of the Thieno[2,3-b]pyridine Anti-Proliferative Agents
por: Zafar, Ayesha, et al.
Publicado: (2018) -
Phosphatidylcholine-Specific Phospholipase C as a Promising Drug Target
por: Eurtivong, Chatchakorn, et al.
Publicado: (2023) -
Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening
por: Sari, Suat, et al.
Publicado: (2019) -
Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative
por: Reynisson, Jóhannes, et al.
Publicado: (2016)